032940 — Wonik Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual income statement for Wonik Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	94,675	108,089	129,877	138,735	150,735
Cost of Revenue
Gross Profit	42,322	50,654	64,044	68,367	71,927
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	88,600	100,692	116,962	129,491	142,036
Operating Profit	6,075	7,397	12,915	9,244	8,699
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	35,817	43,160	3,348	-6,727	14,575
Provision for Income Taxes
Net Income After Taxes	28,432	38,309	-1,384	21,391	11,653
Minority Interest
Net Income Before Extraordinary Items
Net Income	28,488	38,242	-1,724	21,142	11,502
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	28,488	38,242	-1,724	21,142	11,502
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,621	2,098	-110	1,165	661
Dividends per Share